Safety and Efficacy of Praziquantel in Young Children
Author Information
Author(s): Francisca Mutapi, Nadine Rujeni, Claire Bourke, Kate Mitchell, Laura Appleby, Norman Nausch, Nicholas Midzi, Takafira Mduluza
Primary Institution: University of Edinburgh
Hypothesis
Does praziquantel treatment reduce schistosome infection levels in children aged 1–5 years, and are the efficacy rates similar to those in children aged 6–10 years?
Conclusion
Praziquantel treatment is safe and effective for reducing schistosome infection levels in children aged 1–5 years, comparable to older children.
Supporting Evidence
- Pre-treatment infection intensity in 1–5 year olds was 14.6 eggs/10 ml urine.
- 3.8% of children reported mild side effects after treatment.
- PZQ treatment resulted in a 99% egg reduction rate and a 92% cure rate in treated 1–5 year olds.
- The efficacy of praziquantel in 1–5 year olds was comparable to that in 6–10 year olds.
Takeaway
This study shows that a medicine called praziquantel is safe and works well to treat a type of worm infection in young children.
Methodology
Children aged 1–5 years were treated with praziquantel, and side effects were assessed through caregiver questionnaires within 24 hours, with efficacy determined by schistosome egg counts in urine six weeks post-treatment.
Potential Biases
Potential bias in reporting side effects by parents/guardians.
Limitations
The study may have biases in parent/guardian reporting of side effects and did not include untreated controls for all participants.
Participant Demographics
Children aged 1–5 years from three villages in Zimbabwe.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website